Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford undertakes world-leading vaccine research


The development of vaccines for the treatment or prevention of disease is a major strength at Oxford.

Active research programmes for the study of TB, malaria, HIV, HCV, HBV, Ebola virus, Zika virus and several childhood diseases such as meningococcal disease are ongoing.


People in this Theme